Selection of active pharmaceutical ingredients in the development of a solid dosage form based on medicinal raw materials for the treatment of iron deficiency anemia

Abstract

The problem of anemia in young children is of interest to a wide range of specialists, due to its significant prevalence and significant impact on the health of the child population. According to WHO data, on average, in the structure of all anemias, the share of iron deficiency anemia (IDA) is 80-90%. WHO experts have classified iron deficiency anemia as the third most important disease associated with nutritional deficiencies and is one of the leading causes of health problems, especially in young children